All Stories

  1. Chronic Pain and Major Depression: Shared Psychological and Neurobiological Mechanism
  2. Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression
  3. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment
  4. Crosstalk between Depression and Dementia with Resting-State fMRI Studies and Its Relationship with Cognitive Functioning
  5. Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders
  6. Immunomodulatory Effects of Antipsychotic Drugs in Whole Blood Cell Cultures from Healthy Subjects
  7. Rethinking Depression
  8. Treatment Resistance in Psychiatry
  9. Meet Our Editor-in-Chief
  10. Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
  11. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
  12. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
  13. Evidence for additionally increased apoptosis in the peripheral blood mononuclear cells of major depressive patients with a high risk for suicide
  14. Understanding Depression
  15. Understanding Depression
  16. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms
  17. Gender Differences in Depression
  18. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
  19. The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder
  20. Common and distinct brain networks underlying panic and social anxiety disorders
  21. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
  22. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder
  23. Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness
  24. Neuroprotection in Schizophrenia and Its Therapeutic Implications
  25. Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders
  26. Can we cope with treatment refractoriness in psychiatric disorders?
  27. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder
  28. Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
  29. The G allele in IL-10-1082 G/A may have a role in lowering the susceptibility to panic disorder in female patients
  30. Molecular Neurobiology and Promising New Treatment in Depression
  31. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder
  32. Neurobiological Correlates on Psychotherapy in Depression
  33. Biochemical Markers
  34. Molecular neurobiology of major depressive disorder
  35. Decreased Plasma BDNF Levels of Patients with Somatization Disorder
  36. Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?
  37. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression
  38. Cognitive Impairment in Depression
  39. Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment
  40. Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study
  41. Major Depressive Disorder - Cognitive and Neurobiological Mechanisms
  42. Different Mechanisms Between Melancholic and Atypical Depression
  43. The Effects of Psychotherapy on Brain Function — Major Depressive Disorder
  44. Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder
  45. Optimal Treatment for Depression during Pregnancy and Lactation
  46. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer's disease
  47. Evidence for Association between the Brain-Derived Neurotrophic Factor Gene and Panic Disorder: A Novel Haplotype Analysis
  48. Alteration of Brain-Derived Neurotrophic Factor Levels in Panic Disorder
  49. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder
  50. There is no association between the serotonin receptor gene and bipolar I disorder in the Korean population
  51. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
  52. Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
  53. High insulin-like growth factor-1 in patients with bipolar I disorder: A trait marker?
  54. TNF-alpha −308G>A polymorphism is associated with suicide attempts in major depressive disorder
  55. Decreased gray matter volume of the medial orbitofrontal cortex in panic disorder with agoraphobia: A preliminary study
  56. Biological Markers and Genetic Factors of Major Depressive Disorder
  57. Distinguishing Quantitative Electroencephalogram Findings between Adjustment Disorder and Major Depressive Disorder
  58. Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
  59. Anti-Intrusion Effect of Lorazepam: An Experimental Study
  60. Temperament and Character of Young Male Conscripts With Adjustment Disorder
  61. Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: a randomized, open, parallel group study
  62. Characteristics of Type D personality in Korean adolescents
  63. Biological Prediction of Suicidal Behavior in Patients with Major Depressive Disorder
  64. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders
  65. State Effect of Traumatic Experience on Personality Structure
  66. A Case of Blonanserin-Induced Mania in Schizophrenia
  67. Adjunctive treatment of bimodal repetitive transcranial magnetic stimulation (rTMS) in pharmacologically non-responsive patients with schizophrenia: A preliminary study
  68. The Mediating Effect of Psychosocial Factors on Suicidal Probability among Adolescents
  69. Role of cytokines in atypical depression
  70. Paliperidone in the treatment of delirium: results of a prospective open-label pilot trial
  71. The T allele of the interferon-gamma +874A/T polymorphism is associated with bipolar disorder
  72. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients
  73. Suicide and suicidal behavior
  74. Potential peripheral biological predictors of suicidal behavior in major depressive disorder
  75. Effect of Serotonin-Related Gene Polymorphisms on Pathogenesis and Treatment Response in Korean Schizophrenic Patients
  76. Assessment of the Type D Personality Construct in the Korean Population: A Validation Study of the Korean DS14
  77. Gender Effect of Catechol-O-Methyltransferase Val158Met Polymorphism on Suicidal Behavior
  78. No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients
  79. Borna Disease Virus Antibody and RNA from Peripheral Blood Mononuclear Cells of Race Horses and Jockeys in Korea
  80. Psychotropic Drugs on In Vitro Brain-Derived Neurotrophic Factor Production in Whole Blood Cell Cultures From Healthy Subjects
  81. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide
  82. Effect of TGF-β1 polymorphism on the susceptibility to schizophrenia and treatment response to atypical antipsychotic agent
  83. A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder
  84. Efficacy and Tolerability of Blonanserin in the Patients With Schizophrenia
  85. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia
  86. Transforming growth factor-β1 and major depressive disorder with and without attempted suicide: Preliminary study
  87. BDNF MRNA EXPRESSION OF PERIPHERAL BLOOD MONONUCLEAR CELLS WAS DECREASED IN PATIENTS WITH SCHIZOPHRENIA
  88. Association between glycogen synthase kinase-3β gene polymorphisms and major depression and suicidal behavior in a Korean population
  89. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients
  90. The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
  91. Association between Serotonin-Related Polymorphisms in 5HT2A, TPH1, TPH2 Genes and Bipolar Disorder in Korean Population
  92. Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population
  93. Reduced platelet BDNF level in patients with major depression
  94. Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients
  95. Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment
  96. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients
  97. Failure to Detect Borna Disease Virus Antibody and RNA from Peripheral Blood Mononuclear Cells of Psychiatric Patients
  98. Increased Transforming Growth Factor-beta1 in Alcohol Dependence
  99. Manganese superoxide dismutase gene Ala–9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients
  100. The association between serotonin-related gene polymorphisms and panic disorder
  101. A single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor, arginine vasopressin, and proopiomelanocortin in rat brain
  102. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
  103. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients
  104. Association between serotonin-related gene polymorphisms and suicidal behavior in depressive patients
  105. Prediction of postpartum depression by sociodemographic, obstetric and psychological factors: A prospective study
  106. Differences in cytokines between non-suicidal patients and suicidal patients in major depression
  107. Association Study between Antipsychotics- Induced Restless Legs Syndrome and Polymorphisms of Dopamine D1, D2, D3, and D4 Receptor Genes in Schizophrenia
  108. Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
  109. Gender Differences in Suicidal Behavior in Korea
  110. Plasma Brain-Derived Neurotrophic Factor as a Peripheral Marker for the Action Mechanism of Antidepressants
  111. Cognitive Factors for Predicting Treatment Response in Schizophrenic Patients: One-Year Follow-Up Study
  112. Possible association between G-protein β3 subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia
  113. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
  114. Monocytic, Th1 and Th2 Cytokine Alterations in the Pathophysiology of Schizophrenia
  115. Decreased Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Alcohol Dependence
  116. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation
  117. Decreased plasma BDNF level in depressive patients
  118. No Association between Dopamine D4 Receptor Gene –521 C/T Polymorphism and Tardive Dyskinesia in Schizophrenia
  119. Characteristics and clinical correlates of restless legs syndrome in schizophrenia
  120. Cytokine imbalance in the pathophysiology of major depressive disorder
  121. The five-factor gambling motivation model
  122. Gambling Motives Scale
  123. Increased plasma nitric oxide level associated with suicide attempt in depressive patients
  124. The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
  125. No borna disease virus-specific RNA detected in blood of race horses and jockeys
  126. Possible Role of Nerve Growth Factor in the Pathogenesis of Alcohol Dependence
  127. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients
  128. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
  129. Increased Plasma Nitric Oxide Metabolites in Suicide Attempters
  130. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users
  131. G-Protein β3 Subunit C825T Polymorphism Tends to Be Associated with Seasonal Variation in Young Male College Students
  132. Latency of auditory P300 correlates with self-control as measured by the Sixteen Personality Factor Questionnaire
  133. The Role of Cytokine Network in the Pathophysiology of Schizophrenia
  134. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients
  135. The role of the immune system in the pathophysiology of schizophrenia
  136. Th1, Th2 and Th3 cytokine alteration in schizophrenia
  137. A Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium
  138. Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients
  139. Auditory Event-Related Potentials and Psychological Changes during Sleep Deprivation
  140. Abnormal speech perception in schizophrenia with auditory hallucinations
  141. The Effects of Antidepressant Treatment on Serum Cytokines and Nutritional Status in Hemodialysis Patients
  142. Effects of alcohol hangover on cytokine production in healthy subjects
  143. Borna disease virus and deficit schizophrenia
  144. Serum lipid levels and suicide attempts
  145. D2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean population
  146. The role of the cytokine network in psychological stress
  147. Neurobiology of Depression
  148. Low serum cholesterol is correlated to suicidality in a Korean sample
  149. Psychiatric Symptoms Reported by International Peacekeeping Personnel in the Western Sahara Desert
  150. Effect of Risperidone on Serum Cytokines
  151. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
  152. Risperidone and Associated Amenorrhea
  153. Failure to demonstrate Borna disease virus genome in peripheral blood mononuclear cells from psychiatric patients in Korea
  154. Decreased Interleukin-2 Production in Korean Schizophrenic Patients